Product
MMC
3 clinical trials
2 indications
Indication
KeratoconusIndication
Bladder CancerClinical trial
The Effect of Mitomycin C on Corneal Haze and Scarring After Corneal Crosslinking in Keratoconus PatientsStatus: Terminated, Estimated PCD: 2023-02-22
Clinical trial
Treatment of Ta Bladder Cancer in High Risk of Recurrence - Fluorescence Cystoscopy With Optimized Adjuvant Mitomycin-C (FinnBladder 9)Status: Active (not recruiting), Estimated PCD: 2021-12-01
Clinical trial
A Phase 3, Randomized Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Single Agent Intravesical Chemotherapy in Participants With Intermediate-risk Non-muscle Invasive Bladder Cancer (IR-NMIBC) and Susceptible FGFR AlterationsStatus: Recruiting, Estimated PCD: 2028-06-28